Heritage Investment Group’s Pfizer PFE Stock Holding History

Heritage Investment Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,869	Closed	-$218K	–	104
2024 Q1	$218K	Hold	7,869	–	–	0.04%	101
2023 Q4	$227K	Hold	7,869	–	–	0.05%	89
2023 Q3	$261K	Sell	7,869 -1,149	-13%	-$40.6K	0.07%	75
2023 Q2	$331K	Buy	9,018 +1,000	+12%	+$38.9K	0.09%	59
2023 Q1	$327K	Sell	8,018 -8	-0.1%	-$346	0.1%	57
2022 Q4	$411K	Sell	8,026 -600	-7%	-$28.8K	0.13%	47
2022 Q3	$377K	Sell	8,626 -75	-0.9%	-$3.64K	0.23%	48
2022 Q2	$456K	Buy	8,701 +300	+4%	+$15.3K	0.26%	40
2022 Q1	$435K	Buy	+8,401	New	+$436K	0.31%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Heritage Investment Group's PFE Position: Q2 2024 in Review

Heritage Investment Group sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,869 shares — an estimated $218K sold.

Heritage Investment Group first reported a position in PFE in Q1 2022 and held it in 9 quarters. The position peaked at $456K in Q2 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Heritage Investment Group reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Heritage Investment Group sold 7,869 Pfizer shares in Q2 2024, an estimated $218K.
Heritage Investment Group first reported a position in Pfizer in Q1 2022 and held it in 9 quarters.
Heritage Investment Group's Pfizer position peaked at $456K in Q2 2022.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Heritage Investment Group's 13F filing for Q2 2024, filed 22 Jul 2024.